company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4929000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4929000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,83000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,167000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,765000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3890000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3890000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5537000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6500000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,958000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,958000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2932000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4029000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4029000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2246000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8592000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6342000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6342000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-677000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-677000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-677000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1636000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6083000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6083000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,84000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,374000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,788000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4819000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4819000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1248000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4009000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2686000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2686000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1016000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1097000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,81000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,81000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2052000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6992000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6992000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,36000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,771000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-351000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6502000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6502000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37817000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3750000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-34125000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-34125000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-83000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,204000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,121000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,121000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40506000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8358000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8358000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,50000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,304000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,915000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,764000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6325000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6325000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-279000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50594000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7500000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-43373000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-43373000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-334000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2746000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10000000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43774000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50694000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50694000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,996000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,20996000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20996000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-102000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-353000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2419000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-28000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18094000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18094000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,546000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,88661000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-18200000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,71007000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,71007000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,334000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,7396000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-10000000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,1915000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-94578000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-94933000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-94933000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5832000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-804000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-804000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,29000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-770000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-770000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,7201000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7201000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7201000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q1,2015-01-01,2015-03-31,2016-05-16 14:05:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6429000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2585000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2585000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,134000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2401000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2401000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2422000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2872000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2872000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,235000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2644000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2644000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2648000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7061000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7061000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,350000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1610000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1779000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3319000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3319000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5979000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5979000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5979000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2642000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9748000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9748000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,685000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,707000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4639000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3713000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3713000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,8000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,28018000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28010000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28010000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,32108000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32122000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32122000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q1,2016-01-01,2016-03-31,2017-05-12 12:05:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,56419000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13201000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13201000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3346000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5968000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15818000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15818000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,32000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q2,2015-10-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15798000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11370000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11370000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1239000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2824000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7301000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7301000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18229000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,18229000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,18229000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q3,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10895000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12768000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12768000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-41000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1439000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,224000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11138000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11138000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34154000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-53000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-32159000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-32159000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14759000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14759000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14759000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2016.0,Q4,2015-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28538000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11239000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11239000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,126000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1324000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1262000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11006000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11006000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9263000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6930000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2356000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2356000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,57000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,57000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q1,2017-01-01,2017-03-31,2017-05-12 12:05:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13305000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11146000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11146000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-28000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,946000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1338000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8916000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8916000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8287000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,200000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13770000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5662000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5662000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3254000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9170000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9170000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,105000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,753000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,244000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8057000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8057000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4983000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14825000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9842000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9842000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,85000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,96000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,96000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1881000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10893000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10893000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1020000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-641000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10393000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10393000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1991000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11500000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9509000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9509000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,19800000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19841000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19841000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18957000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1038000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8831000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8831000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,95000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1003000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-850000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8572000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8572000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9750000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9750000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9750000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,34000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1212000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:17:04+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,297000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9915000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9915000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,78000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1321000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,615000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7890000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7890000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40141000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40155000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40155000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4963000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42890000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,268000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48121000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48121000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,76000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,342000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17144000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17144000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-37000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1533000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1929000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13707000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13707000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-126000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12124000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4500000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7750000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7750000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4972000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,62000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5061000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5061000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16396000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,467000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16501000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16501000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,30000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1578000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2371000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12502000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12502000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4928000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14000000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9070000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9070000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,47752000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47767000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47767000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44335000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,546000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17189000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17189000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,153000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1251000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3110000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18882000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18882000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1943000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18800000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16856000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16856000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1667000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6627000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,59000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-848000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4171000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4171000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2145000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:18:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,777000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17527000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17527000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,204000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1542000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,597000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15170000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15170000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58304000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15250000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-43072000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-43072000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53194000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,62000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,53256000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,53256000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4986000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,465000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18616000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18616000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,87000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1708000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2216000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14591000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14591000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36020000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11221000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24874000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24874000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,71000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,379000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,450000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,450000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39015000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,702000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16920000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16920000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,230000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1404000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,288000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14971000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14971000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-381000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35000000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,34619000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,34619000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,319000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19967000.0
Eiger BioPharmaceuticals Inc,EIGR,549300N6TVZB9N2Q9M78,0001305253,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,694000.0
